During Vasopressin therapy, which parameter must be monitored most closely?

RML PRE 2025

Pharmacology

Medium

Appeared in: RML PRE 2025

Explanation

Vasopressin's primary physiological role is as an Antidiuretic Hormone (ADH), which increases water reabsorption in the kidneys.
Monitoring urine output provides the most direct, real-time assessment of the drug's primary therapeutic effect (antidiuresis).
A significant decrease in urine output is the earliest warning sign of potential overdose and the life-threatening complication of water intoxication (fluid overload).
This parameter allows for proactive adjustments to prevent severe dilutional hyponatremia, rather than reacting to it after it has already occurred.

Option A: Heart rate is a general vital sign and is not a specific indicator of vasopressin's therapeutic action or primary toxicity.
Option B: While vasopressin is a potent vasoconstrictor, its antidiuretic effect poses a more universal and immediate risk of life-threatening water intoxication. Monitoring urine output is key to preventing this complication.
Option D: Serum sodium levels are a lagging indicator. A drop in sodium (hyponatremia) is the result of excessive water retention. Monitoring urine output is the leading indicator that helps prevent this from happening.

Clinical Relevance

Nursing practice connection: Knowing Pharmacological Monitoring helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
A nurse's primary responsibility during vasopressin therapy is to maintain meticulous fluid balance records (Intake & Output) to prevent iatrogenic water intoxication.
Patient safety is paramount. Early signs of water intoxication include headache, nausea, lethargy, and confusion. The nurse must assess neurological status frequently and report changes immediately.
What if the patient was receiving vasopressin for septic shock? In this case, blood pressure would be the primary therapeutic target to monitor for efficacy. However, urine output would remain the most critical safety parameter to monitor concurrently to prevent fluid overload and hyponatremia.

How to Approach the Question

First, identify the drug mentioned: Vasopressin (also known as ADH).
Recall the primary mechanism of action of this drug. Vasopressin's main function is antidiuresis (reducing urine). It also has a secondary vasopressor (vasoconstriction) effect.
The question asks what to monitor 'most closely'. This requires prioritizing based on the most significant and immediate risk.
Consider the most dangerous complication of the drug's primary action. For vasopressin, this is water intoxication from excessive antidiuresis.
Evaluate the options to see which one provides the earliest and most direct assessment of this primary action and risk. Urine output directly reflects the antidiuretic effect.
Compare this to other options. Blood pressure relates to the secondary effect. Serum sodium is a result (lagging indicator) of water imbalance. Heart rate is non-specific. Therefore, urine output is the priority.

Concept Tested & Keywords

QPSiqgOT9o3NgIvgpmcp6i

E6 Medicine Harrison 22e Part 1 p. 394-396

E6 Nelson Textbook of Pediatrics(2024) — Volume 2 p. 1178-1180